Treatment of Oral Thrush (Oropharyngeal Candidiasis)
For oropharyngeal candidiasis (thrush), fluconazole 200 mg on the first day followed by 100 mg once daily for 7-14 days is the recommended first-line treatment due to its superior efficacy and convenience compared to topical therapies. 1, 2, 3
First-Line Treatment Options
Systemic Therapy
- Fluconazole (preferred):
Topical Therapy Alternatives
- Clotrimazole troches: 10 mg 5 times daily for 7-14 days 2
- Nystatin suspension: 100,000 U/mL, 4-6 mL four times daily for 7-14 days 2, 1
- Nystatin pastilles: 200,000 U each, 1-2 pastilles 4-5 times daily for 7-14 days 1
For Fluconazole-Refractory Cases
Itraconazole solution: 200 mg daily for up to 28 days (64-80% effective in fluconazole-refractory cases) 2, 1
Voriconazole: 200 mg twice daily orally or intravenously for 14-21 days 2
Posaconazole suspension: 400 mg twice daily for 14-21 days 2, 1
Echinocandins (for severe cases):
Amphotericin B deoxycholate: 0.3-0.7 mg/kg daily for 21 days (for severe refractory cases) 2
Important Clinical Considerations
Patient Instructions
- Swish oral suspensions in mouth for as long as possible before swallowing
- Administer after meals to prolong contact time with affected tissues
- For denture wearers:
- Remove dentures before using antifungal medications
- Clean dentures thoroughly daily
- Soak dentures in antimicrobial solution (e.g., chlorhexidine 0.2% if available) 1
Management of Recurrent Infections
- Investigate underlying causes (immunosuppression, diabetes)
- For chronic suppressive therapy: fluconazole 100-200 mg three times weekly 2, 1
- For HIV-infected patients: antiretroviral therapy is strongly recommended to reduce recurrence 2, 1
Monitoring and Follow-up
- Schedule follow-up within 7-10 days to assess treatment response
- Monitor for hepatotoxicity if azole treatment extends beyond 7-10 days 1
- Most patients show improvement within 7 days of starting antifungal therapy 2
Clinical Pearls and Pitfalls
- Fluconazole has superior mycological cure rates compared to topical agents like clotrimazole (49% vs 27%) 5
- Patient compliance is significantly better with once-daily fluconazole compared to multiple daily doses of topical agents 6
- Recurrence following treatment often involves the same Candida strain (74% of cases) 5
- Long-term azole use can lead to development of resistant strains, particularly in immunocompromised patients 5
- Denture-related candidiasis requires both antifungal therapy and proper denture disinfection 2
Fluconazole is the treatment of choice for oropharyngeal candidiasis due to its high efficacy, once-daily dosing, and good systemic absorption, making it more convenient and effective than topical alternatives.